KYUNG NAM PHARM.CO.,LTD.
KOSDAQ
₩2,205.00
+8.62%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Low debt: debt-to-equity of 0.45.
- Net profit margin is 14.2%.
- Current assets comfortably cover current liabilities (current ratio 1.68).
!Watch-points
- Thin interest cover: operating profit covers interest only about -0.1 times.
- Return on equity is on the lower side at 8.8%.
- Return on capital employed is on the lower side at -0.8%.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreDistress zone
0.27
In Altman’s study, scores in this range were associated with a higher incidence of financial distress.
Computed without the market-value term.
Piotroski F-ScoreModerate
4 / 5
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 5 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap₩385억
Current Price₩ 2,205.00
High / Low₩ 5,580.00 / 0.00
Stock P/E17.10
Book Value₩ 1,474.44
ROCE-0.78%
ROE8.75%
Debt to Equity0.45
Current Ratio1.68
EPS₩ 128.94
PAT Margin14.22%
ICR-0.14
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity